Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Market Cap	42.10B
Revenue (ttm)	2.55B
Net Income (ttm)	-1.15B
Shares Out	1.03B
EPS (ttm)	-1.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,512,200
Average Volume	10,337,618
Open	29.92
Previous Close	29.62
Day's Range	29.86 - 30.74
52-Week Range	10.18 - 38.64
Beta	0.64
RSI	46.36
Earnings Date	Oct 28, 2025

About HKG:1877

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,578
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1877

Financial Performance

In 2024, HKG:1877's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.90% less than in 2023.

Financial numbers in CNY